Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system

AS Bell, J Wagner, DB Rosoff, FW Lohoff - Neuroscience & Biobehavioral …, 2023 - Elsevier
The gene encoding proprotein convertase subtilisin/kexin type 9 (PCSK9) and its protein
product have been widely studied for their role in cholesterol and lipid metabolism. PCSK9 …

Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease

M Abifadel, JP Rabès, M Devillers, A Munnich… - Human …, 2009 - Wiley Online Library
Hypercholesterolemia is one of the major causes of coronary heart disease (CHD). The
genes encoding the low‐density lipoprotein receptor and its ligand apolipoprotein B, have …

The activation and physiological functions of the proprotein convertases

NG Seidah, G Mayer, A Zaid, E Rousselet… - The international journal …, 2008 - Elsevier
The mammalian secretory proprotein convertases are part of a family of nine serine
proteinases of the subtilisin-type. Seven of them cleave after basic amino acids and are …

Induction of sustained hypercholesterolemia by single adeno-associated virus–mediated gene transfer of mutant hPCSK9

M Roche-Molina, D Sanz-Rosa, FM Cruz… - … , and vascular biology, 2015 - Am Heart Assoc
Objectives—Patients with mutations in the proprotein convertase subtilisin/kexin type 9
(PCSK9) gene have hypercholesterolemia and are at high risk of adverse cardiovascular …

The genetics of diabetic complications

E Ahlqvist, NR Van Zuydam, LC Groop… - Nature Reviews …, 2015 - nature.com
The rising global prevalence of diabetes mellitus is accompanied by an increasing burden of
morbidity and mortality that is attributable to the complications of chronic hyperglycaemia …

PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax–caspase9–caspase3 pathway

CY Wu, ZH Tang, L Jiang, XF Li, ZS Jiang… - Molecular and cellular …, 2012 - Springer
This paper investigated the effects of ox-LDL on PCSK9, and the molecular mechanisms of
PCSK9 siRNA-inhibited apoptosis induced by ox-LDL in human umbilical vein endothelial …

Clinical aspects of PCSK9

B Cariou, C Le May, P Costet - Atherosclerosis, 2011 - Elsevier
Proprotein convertase subtilisin kexin type 9 (PCSK9) is a circulating protein that impairs
LDL clearance by promoting the LDL receptor (LDLR) degradation. PCSK9 has emerged as …

Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the brain and relevance for neuropsychiatric disorders

EM O'Connell, FW Lohoff - Frontiers in neuroscience, 2020 - frontiersin.org
Proprotein convertase subtilisin/kexin type 9 (PCSK9) has long been studied in the liver due
to its regulation of plasma low-density lipoprotein cholesterol (LDL-C) and its causal role in …

[HTML][HTML] Accelerated atherosclerosis development in C57Bl6 mice by overexpressing AAV-mediated PCSK9 and partial carotid ligation

S Kumar, DW Kang, A Rezvan, H Jo - Laboratory Investigation, 2017 - Elsevier
Studying the role of a particular gene in atherosclerosis typically requires a time-consuming
and often difficult process of generating double knockouts or transgenics on ApoE−/− or LDL …

Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall

Y Guo, B Yan, Y Gui, Z Tang, S Tai… - Journal of cellular …, 2021 - Wiley Online Library
Proprotein convertase subtilisin/kexin type‐9 (PCSK9), a member of the proprotein
convertase family, is an important drug target because of its crucial role in lipid metabolism …